Collegium Pharmaceutical, Inc. Common Stock (NASDAQ: COLL) last traded at $27.11, down 1.56% on the session. The quote above updates while this page is open; the figures below are drawn from Collegium Pharmaceutical, Inc. Common Stock’s own filings and are restated only when a new one is published.
Collegium Pharmaceutical, Inc. Common Stock trades on NASDAQ under the ticker COLL. Its market capitalisation is $882.58 million.
Valuation measures for Collegium Pharmaceutical, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $882.58M |
|---|---|
| Enterprise value | $2.58B |
| P/E ratio | 21.86 |
| Price / sales | 1.09 |
| Price / book | 2.83 |
| Beta | 0.36 |
Trailing-twelve-month figures tagged in Collegium Pharmaceutical, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $808.21M |
|---|---|
| Net income (TTM) | $47.91M |
| EPS (TTM) | $1.24 |
| Gross margin | 60.02% |
| Operating margin | 19.48% |
| Return on equity | 15.36% |
| Cash | $129.47M |
Range and volume for COLL over the past 52 weeks.
| 52-week high | $50.79 |
|---|---|
| 52-week low | $25.47 |
| Volume | 678.3K |
| Average volume | 527.0K |
| Previous close | $27.54 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.